Piperacillin and Tazobactam Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Jan 20, 2026 · last update Jan 20, 2026
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jan 20, 2026 Updated Jan 20, 2026 Discontinued Jan 20, 2026 |